Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim

Overview

About this study

The purpose of this study is to see if advanced endoscopic imaging may be helpful to accurately distinguish pathological tissue from normal tissue and guide therapy of endoscopically identified pathology.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Inflammatory bowel disease
  • Screening colonoscopy
  • Barrett's esophagus
  • Colon polyps
  • Celiac disease

Exclusion Criteria:

  • Platelet count <50,000
  • Unwilling to provide informed consent

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Michael Wallace, M.D.

Open for enrollment

Contact information:

Rachel Pung Page

127or7838513

White.Rachel2@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Kenneth Wang, M.D.

Open for enrollment

Contact information:

Bryan Linn

127or7746050

Linn.Bryan@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available